ロード中...
Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro
BACKGROUND: Treatment options for Stenotrophomonas maltophilia (S. maltophilia) infections were limited. We assessed the efficacy of ceftazidime (CAZ), ceftazidime-avibactam (CAZ-AVI), aztreonam (ATM), and aztreonam-avibactam (ATM-AVI) against a selection of 76 S. maltophilia out of the 1179 strains...
保存先:
| 出版年: | BMC Microbiol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7901100/ https://ncbi.nlm.nih.gov/pubmed/33618662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12866-021-02108-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|